U.S. banks have raced to join the remittance industry in recent years, seeking a share of the billions of dollars immigrants send to their native countries, especially around the holiday season. But as they try to get a piece of the business, many immigrants are reluctant to shift from the smaller mom-and-pop stores and the money transfer services they are accustomed to using to send money home.
With remittances to Latin America and the Caribbean estimated to be a $45 billion (Ђ38 billion) industry, it's no surprise U.S. banks are interested. Many also see remittances as a way to attract new customers to other services. In the last year alone, major banks have unveiled an array of new services to court immigrants away from the hundreds of money transfer services operating in the United States. Wachovia Bank unveiled a card that allows families in Latin America and the Caribbean to withdraw money from an ATM linked to U.S. bank accounts. Wells Fargo Bank expanded its money transfer service to El Salvador and Guatemala, and Bank of America announced it was offering free money transfers to Mexico.
The industry's efforts have won it an estimated 3 percent of the market, according to remittance expert Manuel Orozco, of the Inter-American Dialogue, a Washington, D.C.-based think tank. But despite the banks' efforts, immigrants continue to shy away from sending money through banks for a variety of reasons. In many cases, banks have succeeded in attracting more Hispanic customers but not in getting them to send money, Orozco said.
"They don't think of the bank as a place to send money. They think of the bank as a place to save money," he said. Many immigrants, especially those ere illegally, don't have forms of identification required to do business with banks. Some U.S. banks now accept consular identification cards from countries such as Mexico, Guatemala and Argentina, but customers still need a backup form of ID such as a driver's license or birth certificate, reports the AP. N.U.
Doctors at a US military hospital in Germany discovered an infection in a wounded Ukrainian soldier that could not be treated with any available type of antibiotic drugs